Clinical trials
Withdrawn Phase 1 Schizophrenia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
7 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2012 | 1 |
| 2017 | 1 |
| 2021 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 7 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wyeth is now a wholly owned subsidiary of Pfizer | 2 |
| Central Institute of Mental Health, Mannheim | 1 |
| Centre for Addiction and Mental Health | 1 |
| Otsuka Pharmaceutical Co., Ltd. | 1 |
| University of Maryland, Baltimore | 1 |
| Virginia Commonwealth University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 7 |
| Brain Diseases | 1 |
| Mental Disorders | 1 |
| Neurologic Manifestations | 1 |
| Signs and Symptoms | 1 |
Trials
Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.